About RenalSense
RenalSense is a medical device company dedicated to real-time renal diagnostics. The company’s first-of-its-kind product, Clarity RMS, changes the practice of ICU and critical care management by providing continuous monitoring of urine flow for real-time assessment of renal function and early detection and prevention of ICU-acquired Acute Kidney Injury (AKI).
AKI - Current Medical Practice
Over 30% of critical care patients develop AKI, requiring an average three additional hospital days and $7,500 of additional hospital costs per patient. Mortality rates remain staggeringly high, approaching 83% in those patients with AKI requiring dialysis. Current medical practice in the ICU is to assess kidney function manually and subjectively by measuring and reporting urine volume intermittently
Clarity RMS
The end-to-end, fully automated Clarity RMS is the first commercially available product to facilitate early detection and prevention of ICU-acquired Acute Kidney Injury (AKI). It consists of the following components:
• Electronic Sensor - easily connects to a Foley catheter, where it continuously and reliably measures critical fluctuations in urine flow - the earliest indication of changes in renal function. Automatic data collection and continuous transmission of digital information about renal function reduces labor and prevents human error associated with manual data collection and input.
• Console - consisting of embedded technology in a battery-powered bedside monitor, calculates and transmits the real-time data from the sensor directly to the patient’s electronic medical record (EMR), simultaneously displaying it graphically onscreen.
• Intelligent Alarm System - alerts the medical team as soon as the patient’s urine flow rate is below the pre-set standard for minimum urine output/hour, based on the RIFLE, AKIN, and KDIGO criteria.
|
|
|
1-10 employees
View all RenalSense employees
|
|
Medical Equipment Manufacturing
|
|
Hamrpe 3, Har Hotzvim., P.O.B. 45397, Jerusalem, IL
|
|
2010
|
|
Fluid Management, Nephrology, Early Detection And Prevention Of Acute Kidneys Injury, Icu Aki Screening, Icu Cost Saving., Urine Output, Aki
|
RenalSense Alternatives
Frequently Asked Questions about RenalSense
Avi Kleiman is the CEO of RenalSense. To contact Avi Kleiman email at [email protected]. Or you may call +1.9198767656
The decision makers in RenalSense are Aliza Goldman, Avi Kleiman, Moti Barda, etc. Click to Find RenalSense decision makers emails.
Clarity RMS is a groundbreaking medical device developed by RenalSense that provides real-time monitoring of renal function in critically ill patients. By continuously measuring urine output and other vital parameters, Clarity RMS enables healthcare providers to detect early signs of Acute Kidney Injury (AKI) and manage fluid levels more effectively. This proactive approach not only improves patient outcomes but also optimizes resource utilization in ICU settings.
RenalSense focuses on early detection and prevention of AKI through its innovative Clarity RMS system. By continuously monitoring urine output and other renal indicators, the device alerts clinicians to potential issues before they escalate into severe complications. This early intervention is crucial in critical care environments, where timely responses can significantly reduce the risk of long-term kidney damage and improve overall patient survival rates.
RenalSense primarily serves the healthcare industry, particularly in critical care and nephrology settings. Hospitals, ICUs, and specialized renal units can leverage the Clarity RMS system to enhance patient monitoring, improve fluid management, and reduce the incidence of AKI. Additionally, the technology can be beneficial in research and clinical trials focused on kidney health and disease management.
Clarity RMS contributes to cost savings in ICU settings by enabling early detection of AKI, which can lead to reduced length of stay and lower treatment costs. By preventing the progression of kidney injury, the device minimizes the need for more invasive and expensive interventions, such as dialysis. Moreover, the continuous monitoring provided by Clarity RMS allows for more efficient resource allocation and better patient management, ultimately leading to improved financial outcomes for healthcare facilities.
Clarity RMS stands out due to its real-time continuous monitoring capabilities, which provide clinicians with immediate insights into a patient's renal function. Key features include automated urine output measurement, alerts for abnormal trends, and integration with existing hospital systems for seamless data sharing. This comprehensive approach allows for more informed clinical decision-making and enhances the overall quality of care for patients in critical conditions.
Clarity RMS is designed for use in critically ill patients who are at risk for Acute Kidney Injury, making it particularly suitable for those with underlying conditions such as sepsis, heart failure, or those undergoing major surgeries. While it is an invaluable tool for monitoring renal function in these high-risk populations, the decision to use Clarity RMS should be made by healthcare professionals based on individual patient needs and clinical circumstances.
RenalSense Staff Directory
Search RenalSense Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
